UK-N/A-2400339 | September 2025
Authors:
Carla Prado, PhD, RD
Publish Date:
September 2023 | 31 mins
Abstract:
In this insightful video, Carla Prado discusses the critical aspects of screening and treating muscle loss in oncology patients. She covers the importance of skeletal muscle, the interplay among malnutrition, sarcopenia, physical frailty, cachexia, and the GLIM approach to diagnosing malnutrition. Additionally, Carla highlights key nutritional strategies, including protein and HMB supplementation, to improve patient outcomes.
Once you have watched this video, please remember to complete your self-reflective notes to contribute towards your continuing professional development. You will then be able to access your Certificate of Completion.
LEARNING OBJECTIVES
Discuss the differences between nutrition assessment and screening, and the importance of skeletal muscle in oncology patients.
Describe the interplay among malnutrition, sarcopenia, physical frailty, and cachexia, and their impact on patient outcomes.
Identify key nutritional strategies, including the use of protein and HMB supplementation, to prevent and treat low muscle mass in oncology patients.
AUTHOR(S) BIO
CARLA PRADO, PHD, RD
Director, Human Nutrition Research Unit
Professor/CAIP Chair
Nutrition, Food & Health
University of Alberta
Edmonton, Alberta, CA
Dr Carla Prado is a Professor at the University of Alberta and a Registered Dietitian. She holds a Campus Alberta Innovates Chair in Nutrition, Food and Health and is the Director of the Human Nutrition Research Unit, a state-of-the-art research and training facility. Dr Prado was recently recognized as one of the most influential young Canadian leaders, receiving Canada’s Top 40 Under 40 Award.
Carla is an expert in body composition assessment. Her research programme focuses on the identification and treatment of abnormalities in body composition (especially low muscle mass), with a special interest in cancer. The focus of her current research programme is to develop targeted nutrition interventions for the prevention and treatment of low muscle mass in cancer. She shares her expertise as an Associate Editor of Clinical Nutrition and the Journal of Cachexia, Sarcopenia and Muscle.
Dr Prado received her PhD from the University of Alberta, Canada, and has completed further training at the Cross Cancer Institute (Canada), the National Institutes of Health (USA), and Newcastle University (UK).
